Humacyte Inc. (NASDAQ: HUMA) Stock Information | RedChip

Humacyte Inc. (NASDAQ: HUMA) Listen to this Section


$6.48
+0.3400 ( +5.54% ) 3.0M

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Market Data


Open


$6.48

Previous close


$6.14

Volume


3.0M

Market cap


$773.40M

Day range


$6.13 - $6.69

52 week range


$1.96 - $9.97

Insider Ownership Transactions

Total Amount Purchased: -2,166,702.00 | $ -14,040,228.96

Date Type Amount Purchased Purchaser
2024-06-17 Sale -39389.00 Sebelius Kathleen
2024-06-17 Sale -75000.00 Bamforth John Philip
2024-06-13 Sale -282000.00 Niklason Laura E
2024-06-13 Sale -282000.00 Dougan Brady W
2024-06-04 Buy 2362.00 Dougan Brady W
2024-06-04 Sale -716573.00 Niklason Laura E
2024-06-04 Sale -716573.00 Dougan Brady W
2024-06-04 Buy 2362.00 Niklason Laura E
2024-06-03 Sale -61941.00 Prichard Heather Ledbetter
2024-06-03 Buy 2050.00 Niklason Laura E

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 17, 2024
3 Insider transactions 2 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
3 Insider transactions 2 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.